CDK2 inhibitors | Patent Publication Number 20230159535
US 20230159535 A1Patent NumberUS 11932648 B2
Application Number17850453
Filled DateJun 27, 2022
Priority DateJun 28, 2021
Publication DateMay 25, 2023
Original AssigneeBlueprint Medicines Corporation
Current AssigneeBlueprint Medicines Corporation
Inventor/ApplicantsDouglas Wilson
Richard Vargas
Emanuele Perola
Joseph L. Kim
Natasja Brooijmans
Neil Bifulco, Jr.
Steven Mark Wenglowsky
Philip D. Ramsden
Richard Vargas
Emanuele Perola
Joseph L. Kim
Natasja Brooijmans
Neil Bifulco, Jr.
Steven Mark Wenglowsky
Philip D. Ramsden
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.